|Videos|March 22, 2022
PharmExec CEO Roundtable: Post-COVID Improvements
In this segment, leaders suggest areas to continue building on lessons learned during COVID, including the pharma industry as a tech destination and impact on patient outcomes.
Advertisement
Please read the
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
3
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
4
WHO Finalizes United States’ Withdrawal from Organization: Report
5